تحميل...
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer
OBJECTIVE: To investigate the relationship between BRCA mutation status and response to taxane-based chemotherapy, since BRCA mutation carriers with prostate cancer appear to have worse survival than non-carriers and docetaxel improves survival in patients with castration-resistant prostate cancer....
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2011
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3971723/ https://ncbi.nlm.nih.gov/pubmed/21756279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2011.10292.x |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|